alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Lymphoproliferative-Disorders

alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc has been researched along with Lymphoproliferative-Disorders* in 1 studies

1 review(s) available for alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Lymphoproliferative-Disorders

Article	Year
Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions. Expert opinion on biological therapy, 2020, Volume: 20, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoproliferative Disorders; Oligosaccharides; Sialyl Lewis X Antigen; Skin Diseases; Skin Neoplasms; T-Lymphocytes; Tumor Microenvironment	2020